Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE: March 20142. REPORT TYPE Annual 3. DATES COVERED (From -To)
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERNational Cancer Institute Bethesda, MD 20892
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical ResearchAnd Materiel Command Fort Detrick, MD 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENT :Approved for public release; distribution unlimited
SUPPLEMENTARY NOTES
ABSTRACTOur proposal is to explore the novel notion that it may be possible to restore near normal HR activity in Brca1 cells and tissues. We believe that this phenomenon will lead to targeted therapies to reduce lifetime risk of tumor formation in BRCA1 and potentially BRCA2 carriers.
SUBJECT TERMSBRCA1, 53BP1, cancer biology, DNA repair, tumorigenesis. Appendices……………………………………………………………………………..9
IntroductionGenomic instability is a hallmark of cancer. Central to a cells ability to maintain genomic stability are systems that monitor and repair DNA double strand breaks (DSBs). The objective of this study is to understand how the choice of pathways used to repair DNA damage determines whether the repair is error free or causes genomic instability. In mammalian cells, homologous recombination (HR) and nonhomologous end joining (NHEJ) are the two major pathways involved in the repair of DNA DSBs. The Brca1 gene is required for DNA repair by homologous recombination and normal embryonic development. The protein 53BP1 promotes ligation and facilitates end joining. In previous studies, we have demonstrated that Brca1 and 53BP1 can compete for the processing of DSBs and that 53BP1 can promote genomic instability in the absence of Brca1. Thus, the tumor suppressive function of Brca1 does not appear to be absolute and can be modulated by altering the ability of cells to carryout NHEJ. Our study focuses on shifting the balance between these two repair pathways (HR and NHEJ) to restore error free repair and genomic stability. We believe that a better understanding of mechanisms of DSB repair pathway choice may have ...